NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-160-2006-0-FR-06 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS FR EP 07842310.0 Issued
NCI E-160-2006-0-GB-07 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS GB EP 07842310.0 Issued
NHGRI E-312-2006-0-US-03 Methods for Detecting Attention Deficit Hyperactivity Disorder (ADHD) US National Stage 12/444,898 8003406 Abandoned PDF
NCI E-013-2008-0-US-01 Human Monoclonal Antibodies Against Yeresinia Pestis US 61/212,166 Abandoned
NCI E-154-1998-0-EP-08 RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN EP DIV 09005114.5 Abandoned
NHGRI E-099-2009-0-US-01 Device And Method For Direct Measurement Of Isotopes Of Expired Gases US ORD 12/418,795 8293187 Abandoned PDF
NCI E-266-2008-0-US-02 Single Chain Antibodies that Bind to Chondroitin Sulfate Proteoglycans US ORD 12/418,956 Abandoned
NIDDK E-063-2007-1-US-03 Delivery Of Cross Species A3 Adenosine-receptor Antagonist To Reduce Intracoular Pressure US National Stage 12/419,062 Abandoned
NCI E-207-2008-0-US-02 Dual Specific Immunotoxin for Brain Tumor Therapy US ORD 12/418,975 Abandoned
NIDDK E-063-2007-1-JP-08 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE JP National Stage 2009-531464 Abandoned
NCI E-336-2005-0-MX-11 ANTIBODY COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE MX National Stage 08/12754 Abandoned
NIDDK E-063-2007-1-MX-09 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE MX National Stage MX/A/2009/003750 Pending
NCI E-227-2006-5-US-02 Prevention Of Tissue Ischemia, Related Methods and Compositions US ORD 12/444,364 8236313 Issued PDF
NCI E-338-2008-0-PCT-01 HMGN3 As A Novel Diagnostic Marker For Diabetes PCT PCT PCT/US2009/039406 Expired
NIDDK E-159-2008-0-PCT-02 Polyamine Compounds That Binds Tar RNA of HIV and Methods of Treating Viral Disorders PCT PCT PCT/US2009/002116 Expired
NINDS E-309-2009-0-US-01 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US 61/166,610 Abandoned
NINDS E-081-2008-1-US-01 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US 61/166,610 Expired
NIDDK E-219-2011-1-US-01 CLINICAL DECISION MODEL US 61/166,245 Abandoned
NIEHS E-009-2009-0-AU-03 Inhibition of Inter-Alpha-Trypsin Inhibitor for the Treatment of Airway Disease AU National Stage 2009325088 Abandoned
NCI E-080-2008-0-PCT-02 Human And Improved Murine Monoclonal Antibodies Against CD22 PCT PCT PCT/US2009/039080 Expired
NIEHS E-009-2009-0-PCT-02 Inhibition of Inter-Alpha-Trypsin Inhibitor for the Treatment of Airway Disease PCT PCT PCT/US2009/039157 Expired
NIAID E-306-2006-4-US-07 Avain Influenza Vaccine US National Stage 12/443,964 Abandoned
NCI E-058-2009-0-US-01 Generation And Application Of Antibodies That Bind GaLNAc1-3Gal US 61/165,675 Abandoned
NIEHS E-009-2009-0-CA-04 Inhibition of Inter-Alpha-Trypsin Inhibitor for the Treatment of Airway Disease CA National Stage 2743768 Abandoned
NCI E-332-2007-0-AU-04 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling AU National Stage 2009231841 Abandoned
NCI E-332-2007-0-PCT-03 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling PCT PCT PCT/US2009/038915 Expired
NCI E-332-2007-0-PCT-02 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling PCT PCT PCT/US2009/038896 Expired
NCI E-332-2007-0-EP-06 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling EP National Stage 09727676.0 Abandoned
NCI E-332-2007-0-HK-09 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling HK EP 11106440.0 Abandoned
NCI E-311-2006-1-IT-12 Compositions And Methods For Chitosan Enhanced Immune Response IT EP 07838692.7 Abandoned
NCI E-311-2006-1-BE-05 Compositions And Methods For Chitosan Enhanced Immune Response BE EP 07838692.7 Abandoned
NCI E-311-2006-1-AT-04 Compositions And Methods For Chitosan Enhanced Immune Response AT EP 07838692.7 Abandoned
NCI E-311-2006-1-NL-13 Compositions And Methods For Chitosan Enhanced Immune Response NL EP 07838692.7 Abandoned
NCI E-311-2006-1-ES-09 Compositions And Methods For Chitosan Enhanced Immune Response ES EP 07838692.7 Abandoned
NCI E-311-2006-1-SE-14 Compositions And Methods For Chitosan Enhanced Immune Response SE EP 07838692.7 Abandoned
NCI E-311-2006-1-GB-11 Compositions And Methods For Chitosan Enhanced Immune Response GB EP 07838692.7 Abandoned
NCI E-311-2006-1-CH-06 Compositions And Methods For Chitosan Enhanced Immune Response CH EP 07838692.7 Abandoned
NCI E-311-2006-1-DE-07 Compositions And Methods For Chitosan Enhanced Immune Response DE EP 07838692.7 Abandoned
NCI E-311-2006-1-FR-10 Compositions And Methods For Chitosan Enhanced Immune Response FR EP 07838692.7 Abandoned
NCI E-311-2006-1-DK-08 Compositions And Methods For Chitosan Enhanced Immune Response DK EP 07838692.7 Abandoned
NCI E-332-2007-0-CA-05 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling CA National Stage 2720350 Abandoned
NIDCR E-018-2009-0-US-01 Differentially Expressed MicroRNAs as Biomarkers for the Diagnosis and Treatment of Sjogren's US 61/165,142 Abandoned
NIAID E-329-2000-0-US-07 ACYTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS US CON 12/414,321 8076372 Expired PDF
NIA E-241-2008-0-US-01 Posiphen And Analogues Suppress Production Of Alpha-synculein Protein US 61/164,729 Abandoned
NCI E-227-2006-5-FR-15 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS FR EP 07868382.8 Issued
NCI E-227-2006-5-DE-14 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS DE EP 07868382.8 Issued
NCI E-227-2006-5-GB-16 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS GB EP 07868382.8 Issued
NCI E-129-2008-0-PCT-02 Synthetic Analogs Of Juxtamembrane Domain Of IGF-1 Receptor As Anti-cancer Agents PCT PCT PCT/US09/38620 Expired
NICHD E-124-2008-0-PCT-02 Compounds and Methods for the Treatment of Viral Infection PCT PCT PCT/US2009/038644 Expired
NICHD E-124-2008-0-EP-03 Compounds and Methods for the Treatment of Viral Infection EP National Stage 09751057.2 Abandoned